AVAVA Receives FDA 510(k) Clearance to Treat Benign Pigment Lesions, Including Hyperpigmentation
WALTHAM, Mass., Aug. 17, 2022 (GLOBE NEWSWIRE) -- AVAVA Inc. (“AVAVA” or the “Company”), a disruptive medical aesthetics technology platform company providing breakthrough treatments for all skin tones, today announced that its AVAVA…